| Patents for C07H 21 - Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids (89,892) |
|---|
| 08/25/2009 | US7579326 Gene switch systems employing regulators with decreased dimerization |
| 08/25/2009 | US7579324 Carrier, linker and nonantibiotic therapeutic agent; small molecules; bioavailability, efficacy |
| 08/25/2009 | US7579180 Polypeptides and nucleic acid molecules encoding the polypeptide; such molecules have use as probes for diagnosis of Alzheimer's disease, and for identification of compounds that modulate the activity of beta secretase |
| 08/25/2009 | US7579175 Aqueous culture product using power source; containing aldolase or synthetase |
| 08/25/2009 | US7579169 producing a mutant HH polypeptide by transforming isolated host cells with a vector capable of expressing the polypeptide from the nucleic acid sequence; diagnosis, prenatal screening and diagnosis, and therapies of blood disorders |
| 08/25/2009 | US7579168 Human Dickkopf-related nucleic acid molecules |
| 08/25/2009 | US7579167 Polypeptides involved in the biosynthesis of spiramycins, nucleotide sequences encoding these polypeptides and applications thereof |
| 08/25/2009 | US7579155 Method for identifying the sequence of one or more variant nucleotides in a nucleic acid molecule |
| 08/25/2009 | US7579154 Annealing control primer and its uses |
| 08/25/2009 | US7579151 Isolation and purification method of biomolecules using hydrogel |
| 08/25/2009 | US7579146 Double stranded DNA molecule with a single stranded overhang comprised of RNA; cyclic nucleic acid amplification; directed protein evolution |
| 08/25/2009 | US7579012 Targeting of triacylglycerol synthase gene for tuberculosis treatment |
| 08/25/2009 | US7579011 isolated polypeptide use in vaccines against A. salmonicida infections such as fish disease furunculosis |
| 08/25/2009 | CA2382521C Oligonucleotide n3'.fwdarw.p5' thiophosphoramidates: their synthesis and use |
| 08/20/2009 | WO2009102632A2 Method for isolating cell free apoptotic or fetal nucleic acids |
| 08/20/2009 | WO2009102427A2 Modified rnai polynucleotides and uses thereof |
| 08/20/2009 | WO2009101810A1 Photoresponsive nucleic acid manufacturing method |
| 08/20/2009 | WO2009100617A1 Polypeptide inhibiting angiogenesis and applicaton thereof |
| 08/20/2009 | WO2009100502A1 Immunostimulatory sirna molecules |
| 08/20/2009 | WO2009079376A3 Lepidopteran insect n-acetylglucosaminidase genes and their use in glycoengineering |
| 08/20/2009 | WO2007021841A9 Identification and engineering of antibodies with variant fc regions and methods of using same |
| 08/20/2009 | US20090210966 rice blast susceptibility gene pi21, resistance gene pi21 and uses thereof |
| 08/20/2009 | US20090210958 Nucleic acid encoding n-methylputrescine oxidase and uses thereof |
| 08/20/2009 | US20090210954 Genes |
| 08/20/2009 | US20090209752 Device and method for treating or cleaning sample material, in particular nucleic acids |
| 08/20/2009 | US20090209751 Methods and kits for extraction of dna |
| 08/20/2009 | US20090209750 Organic compound synthesizer and method for synthesizing organic compounds |
| 08/20/2009 | US20090209749 Plant centromere compositions |
| 08/20/2009 | US20090209748 comprise at least one Locked Nucleic Acid (LNA) selected from beta-D-thio/amino-LNA or alpha-L-oxy/thio/amino-LNA; useful in antisense therapy |
| 08/20/2009 | US20090209747 Method to inhibit cell growth using oligonucleotides |
| 08/20/2009 | US20090209732 Secreted and Transmembrane Polypeptides and Nucleic Acids Encoding the Same |
| 08/20/2009 | US20090209730 Method for gene transfer into target cells with retrovirus |
| 08/20/2009 | US20090209627 RNAi-MEDIATED INHIBITION OF CONNEXIN 43 FOR TREATMENT OF IOP-RELATED CONDITIONS |
| 08/20/2009 | US20090209626 Duplex Oligonucleotides with Enhanced Functionality in Gene Regulation |
| 08/20/2009 | US20090209625 Modulation of chrebp expression |
| 08/20/2009 | US20090209623 Anti-sense nucleic acid derived from organism |
| 08/20/2009 | US20090209622 Diagnosis of anxiety disorders |
| 08/20/2009 | US20090209621 Compositions and methods for decreasing microrna expression for the treatment of neoplasia |
| 08/20/2009 | US20090209479 Thiocarbon-protecting groups for rna synthesis |
| 08/20/2009 | US20090209478 Compositions and methods for inhibiting expression of the hamp gene |
| 08/20/2009 | US20090209453 Glycoprotein Hormone Analogs |
| 08/20/2009 | US20090209437 Temperature regulated promoters from schizosaccharomyces pombe for expression of proteins |
| 08/20/2009 | US20090209434 Probe-antiprobe compositions and methods for DNA or RNA detection |
| 08/20/2009 | US20090209432 Detecting targets using nucleic acids having both a variable region and a conserved region |
| 08/20/2009 | US20090209427 Microbial glyphosate resistant epsps |
| 08/20/2009 | US20090209036 Method for Accelerating Somatic Mutations and use Thereof in Proteomics |
| 08/20/2009 | US20090209007 Method of Expression Cloning in a Host Cell |
| 08/20/2009 | US20090209005 Chimeric dna polymerase |
| 08/20/2009 | US20090209004 Human il-1 beta antagonists |
| 08/20/2009 | US20090209003 Mutant pcna |
| 08/20/2009 | US20090209001 2-Deoxy-D-Ribose 5-Phosphate Aldolases (DERAS) And Uses Thereof |
| 08/20/2009 | US20090209000 Genetically Programmed Expression of Proteins |
| 08/20/2009 | US20090208995 Pro-clotting enzyme, and method for detection of endotoxin or (1-3)-beta-d-glucan using the same |
| 08/20/2009 | US20090208990 Human protein acyl transferases and methods of uses therefor |
| 08/20/2009 | US20090208959 Fluorescence-labeled oligonucleotide to detect nucleic acid and method for acquiring information about double-strand formation by using fluorescence-labeled oligonucleotide to detect nucleic acid |
| 08/20/2009 | US20090208956 Primer set for amplifying cyp2c9 gene, reagent for amplifying cyp2c9 gene containing the same, and the uses thereof |
| 08/20/2009 | US20090208954 Primer set for amplification of ugt1a1 gene, reagent for amplification of ugt1a1 gene containing the same, and the uses thereof |
| 08/20/2009 | US20090208949 Phosphatidylinositol phosphate kinase type i gamma splice variants as biomarkers and drug targets for epithelial cancers |
| 08/20/2009 | US20090208948 Detection of toxigenic strains of clostridium difficile |
| 08/20/2009 | US20090208947 Primers, methods and kits for amplifying or detecting human leukocyte antigen alleles |
| 08/20/2009 | US20090208940 Method for detecting c. albicans |
| 08/20/2009 | US20090208936 Identification of molecular interactions and therapeutic uses thereof |
| 08/20/2009 | US20090208932 Methods Of Detecting An Analyte In A Sample |
| 08/20/2009 | US20090208931 Gene Expression Level Normalization Method, Program and System |
| 08/20/2009 | US20090208564 Compositions of asymmetric interfering RNA and uses thereof |
| 08/20/2009 | US20090208530 HIV polynucleotides and polypeptides derived from Botswana MJ4 |
| 08/20/2009 | US20090208529 Recombinant Novirhabdoviruses and Uses Thereof |
| 08/20/2009 | US20090208522 Neutralizing Epitope-Based Growth Enhancing Vaccine |
| 08/20/2009 | US20090208516 Promoter for introducing a gene into a lymphocyte or blood cell and application thereof |
| 08/20/2009 | US20090208514 Method of diagnosing esophageal cancer |
| 08/20/2009 | US20090208505 Mutations of the pik3ca gene in human cancers |
| 08/20/2009 | US20090208491 Compositions and Methods for Diagnosing and Treating Cancer |
| 08/20/2009 | US20090208484 R-spondin compositions and methods of use thereof |
| 08/20/2009 | US20090208474 Biological entities and the use thereof |
| 08/20/2009 | US20090208473 Compositions and methods to modulate cell membrane resealing |
| 08/20/2009 | US20090208468 SUPPRESSORS OF CpG OLIGONUCLEOTIDES AND METHODS OF USE |
| 08/20/2009 | US20090208454 Modified interferon beta polypeptides and their uses |
| 08/20/2009 | US20090208440 Biological entities and the use thereof |
| 08/20/2009 | CA2715354A1 Dominant earliness mutation and gene in sunflower (helianthus annuus) |
| 08/20/2009 | CA2715289A1 Modified rnai polynucleotides and uses thereof |
| 08/20/2009 | CA2714212A1 Method for isolating cell free apoptotic or fetal nucleic acids |
| 08/19/2009 | EP2089722A1 Biomarkers |
| 08/19/2009 | EP2089539A2 Biomarkers related to metabolic age and methods using the same |
| 08/19/2009 | EP2089521A1 Soluble tnf receptors and their use in treatment of disease |
| 08/19/2009 | EP2089411A2 Compositions and methods to treat cancer with cupredoxins and cpg rich dna |
| 08/19/2009 | EP2089410A2 Disposable micropurification cards, methods, and systems thereof |
| 08/19/2009 | EP2089061A1 Inhibition of sox9 function fn the treatment of proteogl ycan-associated pathophysiological conditions |
| 08/19/2009 | EP1144684B1 Enhanced sequencing by hybridization using pools of probes |
| 08/19/2009 | EP1078003B1 Plasmin inhibitors from the australian brown snake, pseudonaja textilis textilis |
| 08/19/2009 | CN101512336A Stimulation of pancreatic beta cell proliferation |
| 08/19/2009 | CN101512008A Interleukin-13 binding proteins |
| 08/19/2009 | CN101512007A Methods and compositions for use in treatment of patients with autoantibody positive diseases |
| 08/19/2009 | CN101511869A Anti-MCP-1 antibodies, compositions, methods and uses |
| 08/19/2009 | CN101511856A Suppressor TRNA transcription in vertebrate cells |
| 08/19/2009 | CN101511181A Proteins, nucleic acids encoding the same and associated methods of use |
| 08/19/2009 | CN101508716A Hair stem cracking liquid |
| 08/19/2009 | CN100529088C Nucleic acid sequences and methods of use for the production of plants with modified polyunsaturated fatty acids |
| 08/19/2009 | CN100529074C Therapeutic binding molecules |
| 08/18/2009 | US7577280 Measurement of mitotic activity |
| 08/18/2009 | US7576271 Maize variety PHF3D |